on MAAT PHARMA (isin : FR0012634822)
Invus Public Equities reduces its stake in MAAT PHARMA
On July 21, 2026, Invus Public Equities, LP announced that it had crossed below the 5% threshold of MAAT PHARMA's share capital and voting rights. This transaction took place on May 15, 2026. On that date, Invus held 876,693 shares, representing 4.65% of the share capital and voting rights.
This decrease in shareholding is the result of a sale of shares on the market. MAAT PHARMA's total share capital consists of 18,863,543 shares, representing an equivalent number of voting rights, in accordance with Article 223-11 of the general regulations.
The French Financial Markets Authority (AMF) has not verified the information provided. The company is controlled by Mr. Raymond Debanne.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all MAAT PHARMA news